Susan L. Morris‐Natschke
ORCID: 0000-0003-3772-0063
· 1 paper in corpus
article
2019
Multidrug resistance presents an obstacle in cancer treatment. Among numerous combative strategies, collateral sensitivity (CS) drugs have opened a new avenue to defeat cancer by exploiting selective toxicity against multidrug-resistant (MD…